BVF Inc’s Orexigen Therapeutics, Inc. OREX Stock Holding History

BVF Inc’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-534,900	Closed	-$108K	–	52
2018 Q1	$108K	Sell	534,900 -200,076	-27%	-$184K	0.01%	43
2017 Q4	$948K	Hold	734,976	–	–	0.11%	42
2017 Q3	$1.56M	Hold	734,976	–	–	0.2%	35
2017 Q2	$2.13M	Hold	734,976	–	–	0.33%	31
2017 Q1	$2.53M	Hold	734,976	–	–	0.43%	28
2016 Q4	$1.28M	Hold	734,976	–	–	0.26%	27
2016 Q3	$2.44M	Buy	734,976 +209,766	+40%	+$792K	0.46%	25
2016 Q2	$2.26M	Buy	+525,210	New	+$2.37M	0.48%	28

Other funds holding OREX

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

BVF Inc's OREX Position: Q2 2018 in Review

BVF Inc sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 534,900 shares — an estimated $108K sold.

BVF Inc first reported a position in OREX in Q2 2016 and held it in 8 quarters. The position peaked at $2.53M in Q1 2017. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

BVF Inc reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
BVF Inc sold 534,900 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $108K.
BVF Inc first reported a position in Orexigen Therapeutics, Inc. in Q2 2016 and held it in 8 quarters.
BVF Inc's Orexigen Therapeutics, Inc. position peaked at $2.53M in Q1 2017.
4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on BVF Inc's 13F filing for Q2 2018, filed 14 Aug 2018.